Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation

Black Diamond Therapeutics, Inc. (BDTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/07/2023 4 RA CAPITAL MANAGEMENT, L.P. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Bought 935,850 shares @ $5, valued at $4.7M
07/06/2023 4 Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Bought 1,000,000 shares @ $5, valued at $5M
07/03/2023 4 BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Bought 1,000,000 shares @ $5, valued at $5M
06/29/2023 4 BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Bought 1,740,000 shares @ $5.4914, valued at $9.6M
06/28/2023 4 Epstein David M. (SEE REMARKS) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Sold 25,000 shares @ $6.7, valued at $167.5k
06/16/2023 4 Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 5,655 shares @ $2.1, valued at $11.9k
06/16/2023 4 DIXON WENDY L (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 5,119 shares @ $2.1, valued at $10.7k
06/16/2023 4 Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 8,929 shares @ $2.1, valued at $18.8k
05/17/2023 4 Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
05/17/2023 4 Mayweg Alexander (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
05/17/2023 4 Shah Rajeev M. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
05/17/2023 4 Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
05/17/2023 4 Menzel Garry E (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
05/17/2023 4 Kulkarni Samarth (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
05/17/2023 4 DIXON WENDY L (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
05/17/2023 4 Dhingra Kapil (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
03/20/2023 4 Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 7,111 shares @ $1.67, valued at $11.9k
03/20/2023 4 DIXON WENDY L (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 6,437 shares @ $1.67, valued at $10.7k
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/19/2022 4 Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 4,532 shares @ $2.62, valued at $11.9k
09/19/2022 4 DIXON WENDY L (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 4,103 shares @ $2.62, valued at $10.7k
09/19/2022 4 Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 4,294 shares @ $2.62, valued at $11.3k
09/19/2022 4 INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 6,584 shares @ $2.62, valued at $17.3k
06/30/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy